AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹245 Cr | ₹359 Cr | ₹133 Cr | ₹70 Cr | ₹155 Cr |
What is the latest Cash Flow from Operating Activities ratio of AARTI DRUGS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹245 Cr |
| Mar2024 | ₹359 Cr |
| Mar2023 | ₹133 Cr |
| Mar2022 | ₹70 Cr |
| Mar2021 | ₹155 Cr |
How is Cash Flow from Operating Activities of AARTI DRUGS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹245 Cr | -31.86 | |
| Mar2024 | ₹359 Cr | 169.22 | |
| Mar2023 | ₹133 Cr | 89.34 | |
| Mar2022 | ₹70 Cr | -54.56 | |
| Mar2021 | ₹155 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,613.2 Cr | 2.6% | 4.9% | -19.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 2.6% |
4.9% |
-19.9% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses